Does the media favor TMCI or OM?

In the previous week, Treace Medical Concepts had 3 more articles in the media than Outset Medical. MarketBeat recorded 6 mentions for Treace Medical Concepts and 3 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.93 beat Treace Medical Concepts' score of 0.79 indicating that Outset Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Outset Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to OM or SGHT?

In the previous week, Outset Medical had 2 more articles in the media than Sight Sciences. MarketBeat recorded 3 mentions for Outset Medical and 1 mentions for Sight Sciences. Outset Medical's average media sentiment score of 0.93 beat Sight Sciences' score of 0.00 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sight Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PROF or OM?

In the previous week, Profound Medical had 1 more articles in the media than Outset Medical. MarketBeat recorded 4 mentions for Profound Medical and 3 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.93 beat Profound Medical's score of 0.49 indicating that Outset Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Outset Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TLSI or OM?

In the previous week, Outset Medical had 2 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 3 mentions for Outset Medical and 1 mentions for TriSalus Life Sciences. Outset Medical's average media sentiment score of 0.93 beat TriSalus Life Sciences' score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TriSalus Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Outset Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Outset Medical (OM) Competitors

$4.06 -0.14 (-3.33%)

Closing price 07/20/2026 04:00 PM Eastern

Extended Trading

$4.07 +0.01 (+0.12%)

As of 07/20/2026 07:34 PM Eastern

Compare

OM vs. CV, TMCI, SGHT, PROF, and TLSI

Should you buy Outset Medical stock or one of its competitors? MarketBeat compares Outset Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Outset Medical include CapsoVision (CV), Treace Medical Concepts (TMCI), Sight Sciences (SGHT), Profound Medical (PROF), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

How does Outset Medical compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Outset Medical (NASDAQ:OM) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

CapsoVision currently has a consensus target price of $8.50, suggesting a potential upside of 25.93%. Outset Medical has a consensus target price of $10.00, suggesting a potential upside of 146.31%. Given Outset Medical's higher probable upside, analysts plainly believe Outset Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

CapsoVision has higher earnings, but lower revenue than Outset Medical. CapsoVision is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	24.89	-$25.32M	-$2.34	N/A
Outset Medical	$119.48M	0.63	-$81.65M	-$4.16	N/A

In the previous week, Outset Medical had 3 more articles in the media than CapsoVision. MarketBeat recorded 3 mentions for Outset Medical and 0 mentions for CapsoVision. Outset Medical's average media sentiment score of 0.93 beat CapsoVision's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
CapsoVision	Neutral
Outset Medical	Positive

Outset Medical has a net margin of -63.65% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Outset Medical	-63.65%	-56.13%	-27.45%

Summary

Outset Medical beats CapsoVision on 8 of the 14 factors compared between the two stocks.

How does Outset Medical compare to Treace Medical Concepts?

Treace Medical Concepts (NASDAQ:TMCI) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Treace Medical Concepts has higher revenue and earnings than Outset Medical. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.29	-$59M	-$0.97	N/A
Outset Medical	$119.48M	0.63	-$81.65M	-$4.16	N/A

Treace Medical Concepts has a net margin of -29.44% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Outset Medical	-63.65%	-56.13%	-27.45%

Treace Medical Concepts presently has a consensus target price of $4.97, indicating a potential upside of 17.49%. Outset Medical has a consensus target price of $10.00, indicating a potential upside of 146.31%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts plainly believe Outset Medical is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

84.1% of Treace Medical Concepts shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by company insiders. Comparatively, 2.5% of Outset Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Treace Medical Concepts has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market. Comparatively, Outset Medical has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market.

In the previous week, Treace Medical Concepts had 3 more articles in the media than Outset Medical. MarketBeat recorded 6 mentions for Treace Medical Concepts and 3 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.93 beat Treace Medical Concepts' score of 0.79 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Outset Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Treace Medical Concepts and Outset Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Sight Sciences?

Outset Medical (NASDAQ:OM) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

Sight Sciences has a net margin of -46.83% compared to Outset Medical's net margin of -63.65%. Sight Sciences' return on equity of -52.34% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Sight Sciences	-46.83%	-52.34%	-28.49%

Outset Medical has a beta of 1.95, meaning that its stock price is 95% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.38, meaning that its stock price is 138% more volatile than the broader market.

Sight Sciences has lower revenue, but higher earnings than Outset Medical. Sight Sciences is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.63	-$81.65M	-$4.16	N/A
Sight Sciences	$77.36M	3.54	-$38.43M	-$0.71	N/A

Outset Medical currently has a consensus price target of $10.00, indicating a potential upside of 146.31%. Sight Sciences has a consensus price target of $8.25, indicating a potential upside of 63.69%. Given Outset Medical's higher possible upside, equities analysts plainly believe Outset Medical is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44

55.5% of Sight Sciences shares are held by institutional investors. 2.5% of Outset Medical shares are held by company insiders. Comparatively, 30.4% of Sight Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Outset Medical had 2 more articles in the media than Sight Sciences. MarketBeat recorded 3 mentions for Outset Medical and 1 mentions for Sight Sciences. Outset Medical's average media sentiment score of 0.93 beat Sight Sciences' score of 0.00 indicating that Outset Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sight Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Sight Sciences beats Outset Medical on 10 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Profound Medical?

Profound Medical (NASDAQ:PROF) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Profound Medical currently has a consensus target price of $12.00, indicating a potential upside of 76.21%. Outset Medical has a consensus target price of $10.00, indicating a potential upside of 146.31%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts clearly believe Outset Medical is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Profound Medical had 1 more articles in the media than Outset Medical. MarketBeat recorded 4 mentions for Profound Medical and 3 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.93 beat Profound Medical's score of 0.49 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Outset Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Outset Medical has a net margin of -63.65% compared to Profound Medical's net margin of -206.76%. Outset Medical's return on equity of -56.13% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-206.76%	-78.88%	-64.06%
Outset Medical	-63.65%	-56.13%	-27.45%

47.9% of Profound Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Comparatively, 2.5% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profound Medical has higher earnings, but lower revenue than Outset Medical. Profound Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	15.37	-$42.57M	-$1.24	N/A
Outset Medical	$119.48M	0.63	-$81.65M	-$4.16	N/A

Profound Medical has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

Summary

Outset Medical beats Profound Medical on 11 of the 16 factors compared between the two stocks.

How does Outset Medical compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

TriSalus Life Sciences has a net margin of -60.85% compared to Outset Medical's net margin of -63.65%. TriSalus Life Sciences' return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-60.85%	N/A	-69.91%
Outset Medical	-63.65%	-56.13%	-27.45%

2.6% of TriSalus Life Sciences shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by company insiders. Comparatively, 2.5% of Outset Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

TriSalus Life Sciences has higher earnings, but lower revenue than Outset Medical. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$45.15M	5.86	-$39.23M	-$1.41	N/A
Outset Medical	$119.48M	0.63	-$81.65M	-$4.16	N/A

TriSalus Life Sciences has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

In the previous week, Outset Medical had 2 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 3 mentions for Outset Medical and 1 mentions for TriSalus Life Sciences. Outset Medical's average media sentiment score of 0.93 beat TriSalus Life Sciences' score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TriSalus Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Outset Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TriSalus Life Sciences presently has a consensus target price of $7.50, suggesting a potential upside of 74.01%. Outset Medical has a consensus target price of $10.00, suggesting a potential upside of 146.31%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts clearly believe Outset Medical is more favorable than TriSalus Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Outset Medical beats TriSalus Life Sciences on 9 of the 16 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OM vs. The Competition

Export

Metric	Outset Medical	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$77.86M	$1.80B	$6.89B	$12.28B
Dividend Yield	N/A	N/A	2.67%	9.39%
P/E Ratio	-0.98	75.92	27.07	23.94
Price / Sales	0.63	24.92	512.71	90.33
Price / Cash	N/A	27.29	26.68	47.25
Price / Book	0.58	5.38	10.63	6.14
Net Income	-$81.65M	-$54.76M	$3.60B	$331.74M
7 Day Performance	-10.57%	-2.18%	-1.24%	-1.82%
1 Month Performance	-19.60%	-0.29%	1.09%	-1.45%
1 Year Performance	-76.81%	-3.24%	23.66%	16.32%

Outset Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OM Outset Medical	3.7422 of 5 stars	$4.06 -3.3%	$10.00 +146.3%	-76.7%	$77.86M	$119.48M	N/A	520
CV CapsoVision	1.9706 of 5 stars	$6.36 +2.3%	$8.50 +33.6%	+48.4%	$310.77M	$13.55M	N/A	90	Positive News
TMCI Treace Medical Concepts	3.533 of 5 stars	$4.44 -3.1%	$4.77 +7.4%	-25.1%	$297.12M	$212.69M	N/A	250
SGHT Sight Sciences	3.1681 of 5 stars	$5.05 -5.4%	$8.25 +63.4%	+44.0%	$290.55M	$77.36M	N/A	210
PROF Profound Medical	1.6435 of 5 stars	$7.10 -0.7%	$12.00 +69.0%	+20.7%	$259.84M	$16.10M	N/A	150	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OM) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Outset Medical (OM) Competitors

OM vs. CV, TMCI, SGHT, PROF, and TLSI

How does Outset Medical compare to CapsoVision?

Summary

How does Outset Medical compare to Treace Medical Concepts?

Summary

How does Outset Medical compare to Sight Sciences?

Summary

How does Outset Medical compare to Profound Medical?

Summary

How does Outset Medical compare to TriSalus Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Outset Medical (OM) Competitors

OM vs. CV, TMCI, SGHT, PROF, and TLSI

How does Outset Medical compare to CapsoVision?

Do analysts prefer CV or OM?

Which has better valuation & earnings, CV or OM?

Does the media refer more to CV or OM?

Is CV or OM more profitable?

Summary

How does Outset Medical compare to Treace Medical Concepts?

Which has preferable earnings & valuation, TMCI or OM?

Is TMCI or OM more profitable?

Do analysts prefer TMCI or OM?

Do insiders & institutionals believe in TMCI or OM?

Which has more risk & volatility, TMCI or OM?

Does the media favor TMCI or OM?

Summary

How does Outset Medical compare to Sight Sciences?

Is OM or SGHT more profitable?

Which has more volatility and risk, OM or SGHT?

Which has better earnings & valuation, OM or SGHT?

Do analysts recommend OM or SGHT?

Do institutionals and insiders have more ownership in OM or SGHT?

Does the media refer more to OM or SGHT?

Summary

How does Outset Medical compare to Profound Medical?

Do analysts rate PROF or OM?

Does the media prefer PROF or OM?

Is PROF or OM more profitable?

Do insiders and institutionals have more ownership in PROF or OM?

Which has preferable valuation and earnings, PROF or OM?

Which has more risk and volatility, PROF or OM?

Summary

How does Outset Medical compare to TriSalus Life Sciences?

Is TLSI or OM more profitable?

Do institutionals and insiders hold more shares of TLSI or OM?

Which has higher earnings & valuation, TLSI or OM?

Which has more volatility and risk, TLSI or OM?

Does the media favor TLSI or OM?

Do analysts recommend TLSI or OM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools